Standard

Immediate results of isolated chemoperfusion of the lung with melphalan and cisplatin in combination with metastasectomy in treatment for resectable metastatic lung lesions. / Levchenko, E. V.; Kalinin, P. S.; Senchik, K. Yu; Mamontov, O. Yu; Gorokhov, L. V.; Barchuk, A. S.; Mishchenko, A. V.

в: Voprosy Onkologii, Том 61, № 6, 2015, стр. 960-964.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Levchenko, EV, Kalinin, PS, Senchik, KY, Mamontov, OY, Gorokhov, LV, Barchuk, AS & Mishchenko, AV 2015, 'Immediate results of isolated chemoperfusion of the lung with melphalan and cisplatin in combination with metastasectomy in treatment for resectable metastatic lung lesions', Voprosy Onkologii, Том. 61, № 6, стр. 960-964.

APA

Levchenko, E. V., Kalinin, P. S., Senchik, K. Y., Mamontov, O. Y., Gorokhov, L. V., Barchuk, A. S., & Mishchenko, A. V. (2015). Immediate results of isolated chemoperfusion of the lung with melphalan and cisplatin in combination with metastasectomy in treatment for resectable metastatic lung lesions. Voprosy Onkologii, 61(6), 960-964.

Vancouver

Levchenko EV, Kalinin PS, Senchik KY, Mamontov OY, Gorokhov LV, Barchuk AS и пр. Immediate results of isolated chemoperfusion of the lung with melphalan and cisplatin in combination with metastasectomy in treatment for resectable metastatic lung lesions. Voprosy Onkologii. 2015;61(6):960-964.

Author

Levchenko, E. V. ; Kalinin, P. S. ; Senchik, K. Yu ; Mamontov, O. Yu ; Gorokhov, L. V. ; Barchuk, A. S. ; Mishchenko, A. V. / Immediate results of isolated chemoperfusion of the lung with melphalan and cisplatin in combination with metastasectomy in treatment for resectable metastatic lung lesions. в: Voprosy Onkologii. 2015 ; Том 61, № 6. стр. 960-964.

BibTeX

@article{79b00790f3a24237b1be7a912e32336f,
title = "Immediate results of isolated chemoperfusion of the lung with melphalan and cisplatin in combination with metastasectomy in treatment for resectable metastatic lung lesions",
abstract = "For treatment of metastatic lung lesions there was used the method of isolated chemoperfusion in combination with metastasectomy. The study included 74 patients (mean age 43 ± 13,4 years). There were performed 99 normothermic isolated chemoperfusions of the lung: with melphalan (39) and cisplatin (60). During surgery there were no lethality outcomes. In the immediate postoperative period it was recorded 1 (1.4%) death developed in 3 days after surgery. The cause of this death was postperfusion lung edema accompanied by increase of signs of respiratory insufficiency. There were following complications after isolated chemoperfusions of the lung: anemia - 23 (23.1%), nausea - 13 (13.1%), vomiting - 5 (5.1%), atrial fibrillation - 10 (10.1%), pneumonia - 2 (2.0%), pulmonary infarction - 2 (2.0%), chylothorax - 1 (1.0%), pneumothorax - 29 (29,3%), emphysema of soft tissues of the chest wall 73 (73,7%). Thus isolated chemoperfusion of the lung with melphalan or cisplatin is a procedure reproducible and relatively safe.",
keywords = "Cisplatin, Isolated chemoperfusion of the lung, Melphala, Metastatic lung lesions",
author = "Levchenko, {E. V.} and Kalinin, {P. S.} and Senchik, {K. Yu} and Mamontov, {O. Yu} and Gorokhov, {L. V.} and Barchuk, {A. S.} and Mishchenko, {A. V.}",
year = "2015",
language = "русский",
volume = "61",
pages = "960--964",
journal = "Вопросы онкологии",
issn = "0507-3758",
publisher = "Медицина",
number = "6",

}

RIS

TY - JOUR

T1 - Immediate results of isolated chemoperfusion of the lung with melphalan and cisplatin in combination with metastasectomy in treatment for resectable metastatic lung lesions

AU - Levchenko, E. V.

AU - Kalinin, P. S.

AU - Senchik, K. Yu

AU - Mamontov, O. Yu

AU - Gorokhov, L. V.

AU - Barchuk, A. S.

AU - Mishchenko, A. V.

PY - 2015

Y1 - 2015

N2 - For treatment of metastatic lung lesions there was used the method of isolated chemoperfusion in combination with metastasectomy. The study included 74 patients (mean age 43 ± 13,4 years). There were performed 99 normothermic isolated chemoperfusions of the lung: with melphalan (39) and cisplatin (60). During surgery there were no lethality outcomes. In the immediate postoperative period it was recorded 1 (1.4%) death developed in 3 days after surgery. The cause of this death was postperfusion lung edema accompanied by increase of signs of respiratory insufficiency. There were following complications after isolated chemoperfusions of the lung: anemia - 23 (23.1%), nausea - 13 (13.1%), vomiting - 5 (5.1%), atrial fibrillation - 10 (10.1%), pneumonia - 2 (2.0%), pulmonary infarction - 2 (2.0%), chylothorax - 1 (1.0%), pneumothorax - 29 (29,3%), emphysema of soft tissues of the chest wall 73 (73,7%). Thus isolated chemoperfusion of the lung with melphalan or cisplatin is a procedure reproducible and relatively safe.

AB - For treatment of metastatic lung lesions there was used the method of isolated chemoperfusion in combination with metastasectomy. The study included 74 patients (mean age 43 ± 13,4 years). There were performed 99 normothermic isolated chemoperfusions of the lung: with melphalan (39) and cisplatin (60). During surgery there were no lethality outcomes. In the immediate postoperative period it was recorded 1 (1.4%) death developed in 3 days after surgery. The cause of this death was postperfusion lung edema accompanied by increase of signs of respiratory insufficiency. There were following complications after isolated chemoperfusions of the lung: anemia - 23 (23.1%), nausea - 13 (13.1%), vomiting - 5 (5.1%), atrial fibrillation - 10 (10.1%), pneumonia - 2 (2.0%), pulmonary infarction - 2 (2.0%), chylothorax - 1 (1.0%), pneumothorax - 29 (29,3%), emphysema of soft tissues of the chest wall 73 (73,7%). Thus isolated chemoperfusion of the lung with melphalan or cisplatin is a procedure reproducible and relatively safe.

KW - Cisplatin

KW - Isolated chemoperfusion of the lung

KW - Melphala

KW - Metastatic lung lesions

UR - http://www.scopus.com/inward/record.url?scp=84962607242&partnerID=8YFLogxK

M3 - статья

C2 - 26995987

AN - SCOPUS:84962607242

VL - 61

SP - 960

EP - 964

JO - Вопросы онкологии

JF - Вопросы онкологии

SN - 0507-3758

IS - 6

ER -

ID: 88744165